Contracts & Grants

Information is courtesy of the Office of Sponsored Projects. Each listing includes the faculty member’s name and school(s) appointments at The University of Texas Health Science Center at Houston, project title, contracting or granting agency, and funding amount.

New

H. Vernon Anderson, Medical School (MS), A Randomized, Double- Blind, Placebo-Controlled Trial Comparing Clopidogrel Plus ASA Versus ASA Alone in Subjects with Acute ST Elevation Myocardial Infarction Treated with Fibrinolytic Therapy EFC5133 (Clarity - TIMI 28), The Brigham and Women’s Hospital Inc., $41,999.

Roberto Arduino, MS, Baylor Center for AIDS Research, Baylor College of Medicine, $10,000.

Bruce Barron, MS, Evaluation of the Efficacy and Safety of Altropane for Differentiating Parkinsonian Syndromes from Non- Parkinsonian Syndromes in Patients with Tremors, Boston Life Sciences Inc., $114,010.

Eric Boerwinkle, School of Public Health (SPH), Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM), Graduate School of Biomedical Sciences (GSBS), Atherosclerosis, Plaque and CVD in Communities, National Institutes of Health (NIH), National Heart, Lung and Blood Institute (NHLBI) $16,406,644; and Novel Genes Influencing Cardiovascular Disease Risk in the Population-At-Large: The ARIC Study, Celera Diagnostics LLC, $66,300.

John Bristol, SPH, Intestinal Parasitic, H. Pylori and Enteroaggregative E. Coli Infection in Relation to Domestic Fecal Contamination in El Paso and Cd. Juarez, Paso Del Norte Health Foundation, $74,582.

Staley Brod, MS, A Phase II/III, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Rituximab in Adults with Primary-Progressive Multiple Sclerosis (PPMS), Genentech Inc., $271,623.

John Byrne, MS and GSBS, Modeling Gene Regulation for Long- Term Plasticity, NIH, National Institute of Neurological Disorders and Stroke (NINDS), $1,094,021.

Rena S. Day, SPH, Molecular Epidemiology of Pancreatic Cancer, The University of Texas M. D. Anderson Cancer Center, $8,849.

Maria E. Fernandez, SPH, A Utilization Focused Evaluation of Two Oncology Education Programs, Texas Cancer Council, $50,000.

Kevin Finkel, MS, A Multi-Center, Open-Label, Randomized Phase II Study to Assess Safety, Duration of Treatment (Up to 72 Hours) and Preliminary Efficacy with the Renal Assist Device (RAD) in Patients with Acute Renal Failure, Nephros Therapeutics Inc., $491,137.

Kenichi Fujise, MS, IMM and GSBS, Investigation of the Role of Fortilin in Vascular Cells, St. Luke's Episcopal Hospital, $50,000.

Brijesh Gill, MS, A Portable Fluid Warming System, Department of the Army, $98,368.

James Grotta, MS, Neuren Pharmaceuticals, Neuren Pharmaceuticals, $62,968.

Adelaide Hebert, MS, An Open-Label Study to Evaluate the Safety of Desonide Foam, 0.05%, Including its Effect on the Hypothalamic Pituitary Adrenal Axis of Adolescent and Pediatric Subjects, Connetics Corporation, $414,005.

Vasanthi Jayaraman, MS and GSBS, A High Throughput Screening Assay for Glutamate Receptors, NIH, National Institute on Alcohol Abuse and Alcoholism, $72,974.

Robert A. Kirken, MS and GSBS, Screening for Small Molecule Inhibitors of Stat5, NIH, NINDS, $74,250.

Susan Landry, MS, Help for Kids Project, Collaborative for Children, $116,186.

Kristina D. Mena, SPH, Optimization of Host Cell Capture and Quantitative Polymerase Chain Reaction for Rapid Detection of Potentially Infectious Viruses in Water, Texas Agriculture Experiment Station, $26,463.

Nancy G. Murray, SPH, Health, Education and Discovering Science and Careers Phase I/II, NIH, National Center for Research Resources, $1,338,876.

Pablo C. Okhuysen, MS, Role of Trehalose Dimycolate in the Pathogenesis of Tuberculosis, Infectious Diseases Society of America Education and Research Foundation, $40,000.

Sharon Ostwald, School of Nursing, Border Intervention by Promotores for Type 2 Diabetes, NIH, National Institute of Nursing Research, $29,165.

John Powers, DB and GSBS, Effect of Polishing Procedures on Surface Texture Parameters and Gloss of Eight Resin Composites with Two Polishing Systems, Ivoclar Vivadent AG, $12,800.

Mary R. Prasad, MS, Caregiver and Environmental Influences on Outcomes from Traumatic Brain Injury in Infants and Preschoolers, U.S. Department of Education, $448,430.

George Stancel, MS and GSBS, Training in Pharmacoinformatics, NIH, National Institute of Digestive Diseases and Kidney Disorders, $2,975,940.

Henry Strobel, MS and GSBS, Human Brain CYP P450s and Psychoactive Drug Metabolism, NIH, National Institute of Mental Health, $1,567,544.

Sally W. Vernon, SPH, A Cancer Study Among Female Veterans in Texas, 1979-2001, NIH, National Cancer Institute (NCI), $147,870.

Richard W. Yee, MS, Molecular Studies of the Thiel-Behnke Corneal Dystrophy, NIH, National Eye Institute, $1,113,750.

Renewal

John Cochran, MS, Children with Special Health Care Needs, Department of State Health Services (DSHS), $100,628.

Jacqueline Hecht, MS and GSBS, Texas Prevalence Study of Idiopathic Talipes Equinovarus (ITEV), DSHS, $40,304.

Steven H. Kelder, SPH, Diffusion of CATCH in Texas Elementary Schools, DSHS, $299,983.

Susan Landry, MS, Head Start Ready to Read, Texas Education Agency, $487,951; Texas Early Education Model (TEEMS), Texas Education Agency, $5,000,000.

Alfred McAlister, SPH, TDH Multi-Cultural Tobacco Prevention and Evaluation Studies, DSHS, $330,000.

Frederick Moore, MS, Pathogenesis of Multiple Organ Failure, NIH, National Institute of General Medical Sciences, $8,026,125.

Hope Northrup, MS and GSBS, Comprehensive Metropolitan and
Outreach Genetic Services, DSHS, $195,298.

Kim Waller, SPH, The Texas Center for Birth Defects Research:
Houston Local Studies, DSHS, $54,329.

Transfer

Stephen K. Tyring, MS, Genetic Resistance to Oncogenic Human Papillomaviruses, NIH, National Cancer Institute, $69,910.